Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch. [electronic resource]
- Transplantation Jun 2014
- 1247-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1534-6080
10.1097/01.TP.0000442782.98131.7c doi
Adult Antibodies, Monoclonal, Murine-Derived--therapeutic use Boston Combined Modality Therapy Communicable Diseases--etiology Complement System Proteins--immunology Cytotoxicity, Immunologic Desensitization, Immunologic--methods Female Graft Rejection--blood Graft Survival--drug effects HLA Antigens--immunology Histocompatibility Humans Immunoglobulins, Intravenous--therapeutic use Immunosuppressive Agents--therapeutic use Isoantibodies--blood Kaplan-Meier Estimate Kidney Transplantation--adverse effects Living Donors Male Middle Aged Neoplasms--etiology Plasmapheresis Risk Factors Rituximab Time Factors Treatment Outcome